Do patient-reported androgen-deprivation therapy side effects predict anxiety and depression among prostate cancer patients undergoing radiotherapy? Implications for psychosocial therapyinterventions

Journal of Psychosocial Oncology

Volumn 30, Issue 2, 2012, Pages 185-197

  Sharpley, Christopher F ^a   Bitsika, Vicki ^b   Christie, David R H ^c  

^a UNIVERSITY OF NEW ENGLAND   (Australia)

^b BOND UNIVERSITY   (Australia)

^c Premion   (Australia)

Author keywords

cancer; hormone therapy; pessimism; prostate

Indexed keywords

HORMONE;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ANHEDONIA; ANXIETY; AROUSAL; ARTHRALGIA; ARTICLE; BONE PAIN; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CONFUSION; DEPRESSION; ENERGY; FATIGUE; FEAR; HUMAN; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; PAIN; PENIS ERECTION; PESSIMISM; PREDICTIVE VALUE; PROSTATE CANCER; PROSTATE CANCER TREATMENT ADHERENCE SCALE; PSYCHOSOCIAL CARE; QUESTIONNAIRE; RATING SCALE; SELF RATING ANXIETY SCALE; SELF RATING DEPRESSION SCALE; SIDE EFFECT; TREATMENT REFUSAL; WEIGHT CHANGE;

ADULT; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANXIETY; COMBINED MODALITY THERAPY; DEPRESSION; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PROSTATIC NEOPLASMS; PSYCHIATRIC STATUS RATING SCALES;

EID: 84859208772     PISSN: 07347332     EISSN: 15407586     Source Type: Journal    
DOI: 10.1080/07347332.2011.651261     Document Type: Article

References (28)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed, Text Revision). Washington, DC: Author.
2. Bolla, M., Van Tienhoven, G., Warde, P., Dubois, J., Mirimanoff, R.-O., Storme, G., . . . Collette, L. (2010). External irridation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC rendomises study. Lancet Oncology, 11, 1066-1073.
3. Christie, K., Meyerowitz, B., Giedzinska-Simons, A., Gross, M., & Agus, D. (2009). Predictors of affect following treatment decision-making for prostate cancer: Conversations, cognitive processing, and coping. Psycho-Oncology, 18, 508-514.
4. DeJonge, J., & Baneke, J. (1989). The Zung Self-Rating Depression Scale: A replication study on reliability, validity and prediction. Psychological Reports, 64, 833-834.
5. Denham, J., Steigler, A., Lamb, D., Joseph, D., Mameghan, H., Turner, S., . . . D'Este, C. (2005). Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial. Lancet Oncology, 6(11), 841-850.
6. Denham, J., Steigler, A., Lamb, D., Joseph, D., Turner, S., Matthews, J., . . . D'Este, C. (2011). Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial. Lancet Oncology, 12, 451-459.
7. DiMatteo, M., Lepper, H., & Croghan, T. (2000). Depression is a risk factor for noncompliance with medical treatment. Archives of Internal Medicine, 160, 2101-2107.
8. Gabrys, J., & Peters, K. (1985). Reliability, discriminant and predictive validity of the Zung Self-Rating Depression Scale. Psychological Reports, 57, 1091-1096.
9. Mottet, N., Prayer-Galetti, T., Hammerer, P., Kattan, M., & Tunn, U. (2006). Optimizing the outcomes and quality of life in the hormonal treatment of prostate cancer. BJU International, 98, 20-27.
10. Partridge, A., LaFountain, A., Mayer, E., Taylor, B., Winer, E. P., & Asnis-Alibozek, A. (2008). Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. Journal of Clinical Oncology, 26, 556-562.
11. Schaefer, A., Brown, J., Watson, C., Plenel, D., DeMotts, J., Howard, M., . . . Ballweg, B. (1985). Comparison of the validities of the Beck, Zung and MMPI depression scales. Journal of Consulting and Clinical Psychology, 53, 415-418.
12. Sharifi, M., Gulley, J., & Dahut, W. (2005). Androgen deprivation therapy for prostate cancer. Journal of the American Medical Association, 294, 238-244.
13. Sharpley, C., Bitsika, V., & Christie, D. (2007). Causal "mapping" of depression among prostate cancer patients: A preliminary interview study. Journal of Men's Health & Gender, 4, 402-408.
14. Sharpley, C., Bitsika, V., & Christie, D. (2008). Psychological distress among prostate cancer patients: Fact or fiction? Clinical Medicine: Oncology, 2, 563-572.
15. Sharpley, C., Bitsika, V., & Christie, D. (2009a). Helping prostate cancer patients understand the causes of anxiety and depression: Comparing cancer-caused vs patient response events. Journal of Men's Health & Gender, 6, 345-353.
16. Sharpley, C., Bitsika, V., & Christie, D. (2009b). Understanding the causes of depression among prostate cancer patients: Development of the Effects of Prostate Cancer on Lifestyle Questionnaire. Psycho-Oncology, 18, 162-168.
17. Sharpley, C., Bitsika, V., & Christie, D. (2010a). How prostate cancer patients cope with the effects of diagnosis and treatment: Development of the Effects of Prostate Cancer Coping Strategies Scale. Journal of Men's Health, 8, 56-65.
18. Sharpley, C., Bitsika, V., & Christie, D. (2010b). Incidence and nature of anxietydepression comorbidity in prostate cancer patients. Journal of Men's Health, 7, 125-134.
19. Sharpley, C., Bitsika, V., & Christie, D. (2010c). "Why I feel bad": Refinement of the Effects of Prostate Cancer upon Lifestyle Questionnaire and an initial explorationof its links with anxiety and depression among prostate cancer patients. Psycho- Oncology, 19, 839-846.
20. Sharpley, C., & Christie, D. (2007a). An analysis of the psychometric structure and frequency of anxiety and depression in Australian men with prostate cancer. Psycho-Oncology, 16, 660-667.
21. Sharpley, C., & Christie, D. (2007b). Patient information preferences among breast and prostate cancer patients. Australasian Radiology, 51, 154-158.
22. Sharpley, C., Christie, D., & Bitsika, V. (2010). Variability in anxiety and depression over time following diagnosis in prostate cancer patients. Journal of Psychosocial Oncology, 28, 644-665.
23. Sharpley, C., & Rogers, H. (1985). Näive versus sophisticated item-writers for the assessment of anxiety. Journal of Clinical Psychology, 41, 58-62.
24. Thomas, B., Thomas, I., Nandamohan, V., Nair, M., & Pandey, M. (2009). Screening for distress can predict loss of follow-up and treatment in cancer patients: Results of development and validation of the Distress Inventory for Cancer Version 2. Psycho-Oncology, 18, 524-533.
25. Zung, W. (1965). A self-rating depression scale. Archives of General Psychiatry, 12, 63-70.
26. Zung, W. (1971). A rating instrument for anxiety disorders. Psychosomatics, 12, 371-379.
27. Zung, W. (1973). From art to science: The diagnosis and treatment of depression. Archives of General Psychiatry, 29, 328-337.
28. Zung, W. (1980). How normal is anxiety? Durham, NC: Upjohn.